265 related articles for article (PubMed ID: 11168931)
1. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium.
Muczynski KA; Cotner T; Anderson SK
Kidney Int; 2001 Feb; 59(2):488-97. PubMed ID: 11168931
[TBL] [Abstract][Full Text] [Related]
2. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
5. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression.
Muczynski KA; Ekle DM; Coder DM; Anderson SK
J Am Soc Nephrol; 2003 May; 14(5):1336-48. PubMed ID: 12707403
[TBL] [Abstract][Full Text] [Related]
6. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
7. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
9. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
10. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
11. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
12. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
13. CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.
Porter KA; Kelley LN; Nekorchuk MD; Jones JH; Hahn AB; de Noronha CM; Harton JA; Duus KM
J Immunol; 2010 Dec; 185(11):6480-8. PubMed ID: 21041720
[TBL] [Abstract][Full Text] [Related]
14. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells.
Chiu BL; Li CH; Chang CC
Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710
[TBL] [Abstract][Full Text] [Related]
15. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.
van Lith M; McEwen-Smith RM; Benham AM
J Biol Chem; 2010 Dec; 285(52):40800-8. PubMed ID: 20959457
[TBL] [Abstract][Full Text] [Related]
16. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis.
Müller CA; Markovic-Lipkovski J; Risler T; Bohle A; Müller GA
Kidney Int; 1989 Jan; 35(1):116-24. PubMed ID: 2468811
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]